Temporal Trends in Artemisinin Partial Resistance and Other Antimalarial Drug Mutations in <i>Plasmodium falciparum</i> from Kagera Region, Northwestern Tanzania, 2021–2023
Alfred Simkin(Brown University), Jeffrey A. Bailey(John Brown University), Neeva Wernsman Young(Brown University), Rashid A. Madebe(National Institute for Medical Research), Abdallah Lusasi(African Malaria Network Trust), Issa Garimo(African Malaria Network Trust), Ally Mohamed(African Malaria Network Trust), Misago D. Seth(National Institute for Medical Research), Daniel Mbwambo(African Malaria Network Trust), Dativa Pereus(National Institute for Medical Research), Deus S. Ishengoma(Kampala International University), Frank Chacky(Ministry of Health, Community Development, Gender, Elderly and Children), Jonathan J. Juliano(University of North Carolina at Chapel Hill), Catherine Bakari(National Institute for Medical Research), Celine I. Mandara(National Institute for Medical Research), Stella Kajange(Ministry of Education and Vocation Training), Abebe A. Fola(John Brown University), Salehe S. Mandai(Ifakara Health Institute), Angelina J. Kisambale(Ifakara Health Institute), Gervas A. Chacha(National Institute for Medical Research), Samwel L. Nhiga(African Malaria Network Trust), Ritha Njau(Muhimbili University of Health and Allied Sciences), Fabrizio Molteni, Sijenunu Aaron(African Malaria Network Trust), Rule B Mrengela(Ifakara Health Institute), Filbert Francis(National Institute for Medical Research)
Cited by 0
Related Papers
Deployment of convalescent plasma for the prevention and treatment of COVID-19
|Journal of Clinical Investigation|2020|863
A Worldwide Map of<i>Plasmodium falciparum</i>K13-Propeller Polymorphisms
|New England Journal of Medicine|2016|574
Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia
|Nature Microbiology|2023|190
Drug-Resistance and Population Structure of Plasmodium falciparum Across the Democratic Republic of Congo Using High-Throughput Molecular Inversion Probes
|The Journal of Infectious Diseases|2018|147
Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance
|The Lancet Infectious Diseases|2024|99